Geneva Partners’s Xilinx Inc XLNX Stock Holding History

Geneva Partners’s Portfolio XLNX Stock Details XLNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-32,313	Closed	-$4.1M	–	73
2019 Q1	$4.1M	Buy	+32,313	New	+$3.63M	3.49%	5

Other funds holding XLNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geneva Partners's XLNX Position: Q2 2019 in Review

Geneva Partners sold out of Xilinx Inc (XLNX) in Q2 2019, closing a stake of 32,313 shares — an estimated $4.1M sold.

Geneva Partners first reported a position in XLNX in Q1 2019 and held it in 1 quarter. The position peaked at $4.1M in Q1 2019. 839 funds tracked by Wall St. Rank hold XLNX as of Q2 2019.

Geneva Partners reported no remaining Xilinx Inc position as of Q2 2019 after selling out during the quarter.
Geneva Partners sold 32,313 Xilinx Inc shares in Q2 2019, an estimated $4.1M.
Geneva Partners first reported a position in Xilinx Inc in Q1 2019 and held it in 1 quarter.
Geneva Partners's Xilinx Inc position peaked at $4.1M in Q1 2019.
839 funds tracked by Wall St. Rank held Xilinx Inc as of Q2 2019.

Based on Geneva Partners's 13F filing for Q2 2019, filed 31 Jul 2019.